miRNAs as Therapeutic Tools and Biomarkers for Prostate Cancer

por Arrighetti, Noemi, Beretta, Giovanni Luca
Publicado 2021

Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma

por Lanzi, Cinzia, Favini, Enrica, Dal Bo, Laura, Tortoreto, Monica, Arrighetti, Noemi, Zaffaroni, Nadia, Cassinelli, Giuliana
Publicado 2021

Synergistic Interaction of Histone Deacetylase 6- and MEK-Inhibitors in Castration-Resistant Prostate Cancer Cells

por Corno, Cristina, Arrighetti, Noemi, Ciusani, Emilio, Corna, Elisabetta, Carenini, Nives, Zaffaroni, Nadia, Gatti, Laura, Perego, Paola
Publicado 2020

Overactive IGF1/Insulin Receptors and NRASQ61R Mutation Drive Mechanisms of Resistance to Pazopanib and Define Rational Combination Strategies to Treat Synovial Sarcoma

por Lanzi, Cinzia, Dal Bo, Laura, Favini, Enrica, Tortoreto, Monica, Beretta, Giovanni Luca, Arrighetti, Noemi, Zaffaroni, Nadia, Cassinelli, Giuliana
Publicado 2019

The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis

por Corno, Cristina, D’Arcy, Padraig, Bagnoli, Marina, Paolini, Biagio, Costantino, Matteo, Carenini, Nives, Corna, Elisabetta, Alberti, Paola, Mezzanzanica, Delia, Colombo, Diego, Linder, Stig, Arrighetti, Noemi, Perego, Paola
Publicado 2022

Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals

por Gatti, Laura, Sevko, Alexandra, Cesare, Michelandrea De, Arrighetti, Noemi, Manenti, Giacomo, Ciusani, Emilio, Verderio, Paolo, Ciniselli, Chiara M., Cominetti, Denis, Carenini, Nives, Corna, Elisabetta, Zaffaroni, Nadia, Rodolfo, Monica, Rivoltini, Licia, Umansky, Viktor, Perego, Paola
Publicado 2014